Citation:
D.A. Berry, E.S. Iversen Jr, D.F. Gudbjartsson, E.H. Hiller, J.E. Garber, B.N. Peshkin, C. Lerman, P. Watson, H.T. Lynch, S.G. Hilsenbeck, and others. 2002. “BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.” Journal of Clinical Oncology, 20, 11, Pp. 2701–2712.